OOIR: Observatory of International Research

Papers

(The H4-Index of Intensive Care Medicine is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Variation in intensive care unit beds capacity in China from 2007 to 2021	556
Obituary and tribute to Professor J. Randall Curtis (Randy)	200
The effects of pantoprazole vs. placebo on 1-year outcomes, resource use and employment status in ICU patients at risk for gastrointestinal bleeding: a secondary analysis of the SUP-ICU trial	176
Effect of proning and recruitment on physio-anatomical variables in COVID-19 pneumonia	174
Time course of physiological variables during inter-hospital helicopter transport of ventilated COVID-19 patients	171
Basic ultrasound skill for intensivists: future scope for expansion of the recommendations of the European Society of Intensive Care Medicine	156
Full enteral nutrition should be avoided among patients with high vasopressor dose and low flow state	147
Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis	140
Weaning strategy in patients at low-to-medium risk of extubation failure	138
Workplace equity for clinicians with a disability: why it matters for all	137
Major adverse kidney events as an endpoint in acute kidney injury trials: is it time for a RE-MAKE?	135
Personalized oxygen targets are needed for extracorporeal membrane oxygenation	127
Preventing stress ulcer bleeding	123
No ventilation, no ARDS: insights from four-dimensional computed tomography as dynamic imaging	109
Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction	106
Close collaboration between pathologists and intensivists to understand (not just) coronavirus disease	105
The certainty of parental love vs. the uncertainty of a “best” decision	102
Optimal oxygen and mean arterial blood pressure targets after cardiac arrest	98
Pitfalls in the use of microcirculation as a resuscitation goal	97
Correction to: Noninvasive respiratory support in intensive care medicine	95
Norepinephrine dose and concentration reporting: a closer look at the fine print	94
Staircase strategy, tier-three therapies, and effects on outcome in traumatic brain injured patients: the Triple-T TBI study	91
Lung-protective sedation: moving toward a new paradigm of precision sedation	86
Dose of norepinephrine: the devil is in the details	85
Status epilepticus in the ICU	84

Measuring patient’s effort on the ventilator	81
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury	80
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial	78
Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST): a prospective, multi-centre, cohort study	78
Using the helmet	77
Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort study	76
Persistent signs of poisoning after massive drug ingestion: move the ultrasound probe to the stomach	76
Comparing intravascular and surface cooling methods: a critical look at outcomes for out-of-hospital cardiac arrest patients—author's reply	74
Beyond inflammation: the role of metabolic dysregulation in sepsis diagnosis and treatment	72
Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs	72
Serum sickness: a mimic of septic shock	71
A double plea for dyspnea as the next great cause of all ICU professions and for caution about the dyspnea-breathlessness equivalence	69
Sequencing interventions in ARDS: the critical role of timing and order in standardized management	68
Severe Pneumocystis jirovecii pneumonia: time to reassess our practices	68
Greenery and outdoor facilities to improve the wellbeing of critically ill patients, their families and caregivers: things to consider	65
Correction: Expanding the role of PoCUS in tailoring diuretic strategies for congestion management in critical care	62
18F-fluorodeoxyglucose positron emission tomography/computed tomography differentiates between pneumonia and atelectasis in a mechanically ventilated patient	62
Anesthetic drugs for rapid sequence intubation: ketamine, but what dose?	61
Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial	60
Frailty in intensive care medicine must be measured, interpreted and taken into account!	58
Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions	58
Long-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia	58
ICU venous thromboembolism prophylaxis: revisiting external validity, vulnerable subgroups, and diagnostic standards, with future directions. Authors' reply	56
SHAP model explainability in ECMO–PAL mortality prediction: a critical analysis	56
Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry	54
Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis	53
Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock	53
B-ICONIC vs. Reality: The Feasibility Gap in Neuro-Ultrasound Recommendations and Achievability. Authors’ reply	52
Less is more. Atmospheric and environmental stakes - sedate with care	52